GENZYME TRANSGENICS CORP
10-Q, EX-27, 2000-08-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENZYME TRANSGENICS CORP, 10-Q, 2000-08-09
Next: EUROWEB INTERNATIONAL CORP, 10QSB, 2000-08-09



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUL-02-2000
<CASH>                                          36,573
<SECURITIES>                                    31,875
<RECEIVABLES>                                   11,411
<ALLOWANCES>                                       701
<INVENTORY>                                        653
<CURRENT-ASSETS>                                93,338
<PP&E>                                          52,168
<DEPRECIATION>                                  16,946
<TOTAL-ASSETS>                                 148,001
<CURRENT-LIABILITIES>                           26,455
<BONDS>                                         12,651
                                0
                                          0
<COMMON>                                           290
<OTHER-SE>                                     107,818
<TOTAL-LIABILITY-AND-EQUITY>                   148,001
<SALES>                                         40,102
<TOTAL-REVENUES>                                40,102
<CGS>                                           36,063
<TOTAL-COSTS>                                   47,564
<OTHER-EXPENSES>                               (1,590)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 920
<INCOME-PRETAX>                                (6,792)
<INCOME-TAX>                                       148
<INCOME-CONTINUING>                            (6,940)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,014)
<EPS-BASIC>                                     (0.26)
<EPS-DILUTED>                                   (0.26)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission